TABLE 2.
Enzyme | Substrate | Kmapp(2OG) | Kmapp(peptide) | Kmapp(O2) | kcatapp |
---|---|---|---|---|---|
μm | μm | μm | s−1 | ||
FIH | HIF-1α CAD35-mer | 110 ± 20 | 180 ± 30 | 110 ± 30 | 0.56 ± 0.04 |
FIH | HIF-2α CAD35-mer | 19 ± 6a | 315 ± 40a | 110 ± 10 | 0.049 ± 0.005 |
PHD2 | HIF-1α CODD | 13 ± 2 | 10 ± 6 | 460 ± 30 | 0.060 ± 0.006 |
PHD2 | HIF-1α NODD | 30 ± 9 | 11 ± 2 | >450 | 0.028 ± 0.001 |
PHD2 | HIF-2α CODD | 9 ± 2 | 34 ± 10 | >450 | 0.069 ± 0.006 |
PHD2 | HIF-2α NODD | 17 ± 5 | 50 ± 8 | 410 ± 80 | 0.013 ± 0.001 |
a Substrate inhibition at 2OG concentrations >100 μm and HIF-2α CAD35-mer concentrations >700 μm was observed.